Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$534,101
+$42,399 QoQ
Shares Held
3,408
+5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#858
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chicago Partners Investment Group LLC holds $61,906,541 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,216 | $21,848,818 | |
| 2 | ABBV |
AbbVie Inc.
|
59,244 | $14,908,160 | |
| 3 | JNJ |
Johnson & Johnson
|
30,694 | $7,795,355 | |
| 4 | MRK |
Merck & Co., Inc.
|
39,284 | $5,047,994 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
60,440 | $3,482,552 | |
| 6 | AMGN |
Amgen Inc
|
6,922 | $2,506,594 | |
| 7 | PFE |
Pfizer Inc
|
96,817 | $2,331,353 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,079 | $1,273,380 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $534,101 | 3,408 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $491,702 | 3,219 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $399,823 | 2,900 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $340,348 | 2,654 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $307,002 | 2,537 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $278,142 | 2,495 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $232,376 | 2,388 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||